Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07464158 · ClinicalTrials.gov registry record · NA
WRITE: Written Imaginal Thinking Exercise Study
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 353
- Enrollment target
NCT07464158: Completed NA study, sponsored by University of Colorado, Boulder.
NCT07464158 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 353 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07464158, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 353 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate and compare the effects of three different versions of a future imaginal writing exercise (worst-case scenario, neutral future scenario, best-case scenario) for individuals with elevated social anxiety symptoms. Participants (estimated N=270) will be recruited through the online platform, Prolific, and will be randomly assigned to one of three writing exercise conditions. Participants will complete three study sessions across approximately three weeks. Study session 1 (T1) will consist of baseline assessments and pre-writing ratings, a future imaginal writing exercise, and then post-writing ratings. Study session 2 (T2) will occur approximately one week later and will consist of mid-study assessments and pre-writing ratings, a second, repeated future imaginal writing exercise, and then post-writing ratings. Finally, study session 3 (T3) will occur approximately one week later (approximately two weeks after T1) and will consist of follow-up assessments and repeated post-writing ratings.
Primary Outcome
Social anxiety symptom severity, range: 0-68 total, higher scores indicate higher social anxiety symptom severity.
Interventions
- BEHAVIORAL Worst-Case Scenario Written Exposure Exercise
- BEHAVIORAL Neutral Future Scenario Written Exercise
- BEHAVIORAL Best-Case Scenario Written Exposure Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 353 participants |
| Start Date | 2026-03-21 |
| Est. Completion | 2026-06-05 |
| Phase | NA |
What the finished NCT07464158 record still lists
NCT07464158 is an interventional study that assigns participants to a tested intervention. The registered 353 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 3 interventions - of which Worst-Case Scenario Written Exposure Exercise is the first listed.
NCT07464158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07464158 about?
NCT07464158 is a clinical study titled "WRITE: Written Imaginal Thinking Exercise Study". The purpose of the study is to investigate and compare the effects of three different versions of a future imaginal writing exercise (worst-case scenario, neutral future scenario, best-case scenario) for individuals with elevated social anxiety symptoms. Participants (estimated N=270) will be recrui...
What is the current status of trial NCT07464158?
This trial is currently completed. It is a NA study. The enrollment target is 353 participants. The study started on 2026-03-21. Estimated completion is 2026-06-05.
What interventions are being tested in trial NCT07464158?
The interventions under investigation include: Worst-Case Scenario Written Exposure Exercise (BEHAVIORAL), Neutral Future Scenario Written Exercise (BEHAVIORAL), Best-Case Scenario Written Exposure Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT07464158?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07464158's enrollment target sits among peer trials
353 292nd of 2000 higher than 1,709 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05548296 · 353 participants · Phase 2
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- NCT05884775 · 353 participants · NA
Novel Digital Patient-Reported Outcomes Tool for Diabetes Management
- NCT02579967 · 354 participants · Phase 2
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- NCT02610413 · 354 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI